🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07023224
Recruiting Observational

Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

NCT07023224 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2024-11-14
Last updated
2025-09-19

Condition(s) studied

Idiopathic Parkinson DiseaseDyskinesiasQuality of Life

Investigational drug(s) / intervention(s)

Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)

Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26): The Turkish adaptation of the Parkinson's Disease Dyskinesia Scale (PDYS-26) is administered to individuals diagnosed with Parkinson's disease who have a dyskinesia score of ≥1 based on the Unified Parkinson's Disease Rating Scale (UPDRS) dyskinesia item. The scale is used to evaluate dyskinesia severity and assess its clinical applicability in Turkish-speaking populations.

Study summary

The aim of this methodological study was to investigate the Turkish validity and reliability of the Parkinson's Disease Dyskinesia Scale (PDYS-26).The scale evaluates choreic dyskinesia.Measures the impact of dyskinesia on activities of daily living in patients with Parkinson's disease.

Hypotheses of the Study:

* Parkinson's Disease Dyskinesia Scale (PDYS-26) is reliable in Turkish.
* Parkinson's Disease Dyskinesia Scale (PDYS-26) is valid in Turkish.

To determine the validity of dyskinesia;

* Tampa Kinesiophobia Scale,
* Mini BesTest,
* Activity Specific Balance Safety Scale (ABC) and
* Parkinson's Disease Questionnaire-39 will be evaluated.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being diagnosed with idiopathic Parkinson's disease * H\&Y stage 1-3 * UPDRS dyskinesia item score ≥1 * Accepting to participate in the study Exclusion Criteria: * Diagnosis of atypical-secondary parkinsonism * Severe musculoskeletal, neurological and/or cardiopulmonary problems that may affect the results of the assessment * Mini Mental State Examination score \< 24

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Bakirçay University Çiğli Regional Education Hospital Izmir İ̇zmi̇r Recruiting
Izmir Bakırçay Univercity Izmir Turkey (Türkiye) Recruiting

More Izmir Bakircay University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07023224 on ClinicalTrials.gov ↗ ← All trials in Turkey